Hepatitis C and injecting drug use: the realities of stigmatisation and discrimination.
Hepatitis C and injecting drug use: the realities of stigmatisation and discrimination.
复制标题
DOI：
10.1177/001789690306200307
复制
发表时间：
2003-01-01
影响因子：
1.3
通讯作者：
Adorjany, L. V.
中科院分区：
文献类型：
--
作者：
Habib, S. E.;Adorjany, L. V.
目的：调查澳大利亚悉尼注射吸毒者所经历的与丙型肝炎病毒 (HCV) 感染相关的歧视和污名化程度。设计：通过注射吸毒者 (IDU) 的自填问卷收集数据。问题包括基本人口统计、注射和性史、HCV 知识、风险实践、自我报告的 HCV 诊断、歧视和污名化经历，以及针头和注射器计划 (NSP) 提供的减少伤害服务。定性和定量数据都是从注射吸毒者那里收集的。背景：向悉尼大都市区的 NSP 客户分发调查问卷。方法：选择10个NSP和1个美沙酮诊所。向所有这些网点发放了调查问卷，共招募了 274 人。选定地点的工作人员在分发注射用具的同时，要求顾客填写调查问卷。结果：据报告，大多数与丙型肝炎病毒相关的吸毒者歧视发生在医疗保健机构中。 52% 的参与者由于丙肝病毒呈阳性而经历过这种情况。此外，超过一半的样本（65%）表示这种歧视实际上是由于吸毒者造成的。女性比男性更有可能因其丙肝病毒状况而遭受歧视。结论：由于对吸毒者的陈规定型观念，医疗保健机构中普遍存在歧视和污名化现象。需要查明并消除注射吸毒者获得卫生服务的障碍。在卫生专业人员中开展宣传活动将是解决这一问题的可行方法。
Objective: To examine the extent of discrimination and stigmatization related to hepatitis C virus (HCV) infection, as experienced by injecting drug users in Sydney, Australia. Design: Data were collected through a self-administered questionnaire from injecting drug users (IDUs). Questions included basic demographics, injecting and sexual history, HCV knowledge, risk practices, self-reported HCV diagnosis, and experiences of discrimination and stigmatization, as well as harm reduction services provided by needle and syringe programmes (NSPs). Both qualitative and quantitative data were collected from IDUs. Setting: Questionnaires were distributed to clients of NSPs in the Sydney metropolitan area. Method: Ten NSPs and one methadone clinic were selected. Questionnaires were distributed to all of these outlets and a total of 274 persons were recruited. The staff at the selected sites asked clients to fill out the questionnaire while distributing injecting equipment. Results: Most HCV related discrimination against drug users was reported in health care settings. Fifty-two percent of the participants experienced this as a result of being HCV positive. In addition, more than half of the sample (65%) reported that such discrimination was actually as a result of being a drug user. Females were more likely than males to experience discrimination because of their HCV status. Conclusion: The level of discrimination and stigmatization was widespread in health care settings, resulting from the stereotyping of IDUs. The barriers to IDUs accessing health services need to be identified and removed. Implementation of an awareness campaign among health professionals would be a feasible way to address this issue.